|
Andrew Bonfield joined Bristol-Myers Squibb in September 2002, and is responsible for the company’s worldwide finance operation including Tax, Treasury, Control, Investor Relations Internal Audit, Financial Shared Services, Global Strategic Sourcing and Information Management.
Previously, Bonfield served as director of Finance at the BG Group, PLC, an international energy company. Prior to that, he was chief financial officer at SmithKline Beecham now Glaxo SmithKline responsible for all aspects of the company’s finances, including corporate control, operations, finance, tax, strategy and development.
Bonfield holds a Bachelor of Commerce degree from the University of Natal in Durban, South Africa, and is professionally certified as a chartered accountant.
July 28, 2003 Bonfield was appointed a non-executive Director of the BOC Group in the U.K. | 